These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel zinc finger gene is fused to EWS in small round cell tumor. Mastrangelo T, Modena P, Tornielli S, Bullrich F, Testi MA, Mezzelani A, Radice P, Azzarelli A, Pilotti S, Croce CM, Pierotti MA, Sozzi G. Oncogene; 2000 Aug 03; 19(33):3799-804. PubMed ID: 10949935 [Abstract] [Full Text] [Related]
3. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF. Clin Cancer Res; 2003 Dec 15; 9(17):6389-94. PubMed ID: 14695139 [Abstract] [Full Text] [Related]
6. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R. Carcinogenesis; 2004 May 15; 25(5):693-701. PubMed ID: 14729589 [Abstract] [Full Text] [Related]
7. Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Dallol A, Krex D, Hesson L, Eng C, Maher ER, Latif F. Oncogene; 2003 Jul 17; 22(29):4611-6. PubMed ID: 12881718 [Abstract] [Full Text] [Related]
8. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E. Breast Cancer Res; 2008 Jul 17; 10(5):R82. PubMed ID: 18826564 [Abstract] [Full Text] [Related]
9. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer. Kikuchi R, Tsuda H, Kozaki K, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I. Cancer Res; 2008 Jul 01; 68(13):5067-75. PubMed ID: 18593905 [Abstract] [Full Text] [Related]
11. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Ladanyi M, Gerald W. Cancer Res; 1994 Jun 01; 54(11):2837-40. PubMed ID: 8187063 [Abstract] [Full Text] [Related]
12. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Verma M, Ebina Y, Nomura E, Yamamoto R, Sakuragi N, Dahiya R. Biochem Biophys Res Commun; 2004 Apr 16; 316(4):1156-62. PubMed ID: 15044106 [Abstract] [Full Text] [Related]
13. Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation. Speleman F, Delattre O, Peter M, Hauben E, Van Roy N, Van Marck E. Mod Pathol; 1997 May 16; 10(5):496-9. PubMed ID: 9160316 [Abstract] [Full Text] [Related]
14. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Bärlund M, Monni O, Weaver JD, Kauraniemi P, Sauter G, Heiskanen M, Kallioniemi OP, Kallioniemi A. Genes Chromosomes Cancer; 2002 Dec 16; 35(4):311-7. PubMed ID: 12378525 [Abstract] [Full Text] [Related]
19. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Tobias ES, Hurlstone AF, MacKenzie E, McFarlane R, Black DM. Oncogene; 2001 May 17; 20(22):2844-53. PubMed ID: 11420696 [Abstract] [Full Text] [Related]
20. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC. Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529 [Abstract] [Full Text] [Related] Page: [Next] [New Search]